Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1274695

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of moving stem cell transplant recipients who have a non malignant blood disorder and who are clinically extremely vulnerable from covid-19 vaccine priority level six to four.
tabling member constituency	Sheffield South East
tabling member printed	Mr Clive Betts
uin	134336
answer	answer is ministerial correction date of answer 09/04/2021 answer text <p>People who have received a stem cell transplant more than six months ago are included within priority group six of phase one. People who have received a stem cell transplant within the last six months will be defined as clinically extremely vulnerable in which case they are included in priority group four. Both groups should now have been called forward for vaccination.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/04/2021 12:45:13 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73528 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	394 label Biography information for Mr Clive Betts

1274707

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will prioritise teachers in special schools for the covid-19 vaccine.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	134333
answer	answer is ministerial correction date of answer 12/03/2021 answer text <p>We have no plans to prioritise teachers and key workers by their occupation.</p><p>The Joint Committee on Vaccination and Immunisation’s interim advice for phase two of the vaccination programme sets out the most effective way to minimise hospitalisations and deaths is to continue to prioritise people by age.</p><p> </p><p>If teachers or key workers are captured in phase one or two due to their age or clinical need they will be vaccinated accordingly.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 134245 134246 question first answered 12/03/2021 15:51:09 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73527 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	253 label Biography information for Mr Laurence Robertson

1274717

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of the Pfizer/BioNTech covid-19 vaccine if the second dose is administered 12 weeks after the first dose.
tabling member constituency	Manchester, Gorton
tabling member printed	Afzal Khan
uin	134547
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>A recent study demonstrated a two-dose vaccine efficacy of 95% for the Pfizer/Biotech COVID-19 vaccine, with a second dose delivered between 19 and 42 days. The Joint Committee on Vaccination and Immunisation (JCVI) has reviewed evidence on the Pfizer/BioNTech COVID-19 vaccine and advised an interval of up to 12 weeks between doses. The considerations of the JCVI on extended intervals has been published, and is available here: <a href="https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement" target="_blank">https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement</a></p><p>Using data available from clinical trials, Public Health England estimated that vaccine efficacy from the first dose of the Pfizer/BioNTech vaccine is approximately 89%. This is the efficacy calculated 15 to 21 days after the first dose. The estimate for 15 to 28 days is 91% which includes seven days after the second dose, but is prior to the time protection that may be expected from the second dose. There is no estimate of efficacy for a single dose beyond 21 days, but the JCVI’s view is that protective immunity from the first dose likely lasts for a duration of 12 weeks.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 134548 134549 question first answered 18/01/2021 11:48:46 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73470 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4671 label Biography information for Afzal Khan

1274718

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of the Pfizer/BioNTech covid-19 vaccine if the second dose is administered three weeks after the first dose.
tabling member constituency	Manchester, Gorton
tabling member printed	Afzal Khan
uin	134548
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>A recent study demonstrated a two-dose vaccine efficacy of 95% for the Pfizer/Biotech COVID-19 vaccine, with a second dose delivered between 19 and 42 days. The Joint Committee on Vaccination and Immunisation (JCVI) has reviewed evidence on the Pfizer/BioNTech COVID-19 vaccine and advised an interval of up to 12 weeks between doses. The considerations of the JCVI on extended intervals has been published, and is available here: <a href="https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement" target="_blank">https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement</a></p><p>Using data available from clinical trials, Public Health England estimated that vaccine efficacy from the first dose of the Pfizer/BioNTech vaccine is approximately 89%. This is the efficacy calculated 15 to 21 days after the first dose. The estimate for 15 to 28 days is 91% which includes seven days after the second dose, but is prior to the time protection that may be expected from the second dose. There is no estimate of efficacy for a single dose beyond 21 days, but the JCVI’s view is that protective immunity from the first dose likely lasts for a duration of 12 weeks.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 134547 134549 question first answered 18/01/2021 11:48:46 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73466 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4671 label Biography information for Afzal Khan

1274719

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the evidence for the decision to administer the second dose of the Pfizer/BioNTech covid-19 vaccine 12 weeks after the first dose.
tabling member constituency	Manchester, Gorton
tabling member printed	Afzal Khan
uin	134549
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>A recent study demonstrated a two-dose vaccine efficacy of 95% for the Pfizer/Biotech COVID-19 vaccine, with a second dose delivered between 19 and 42 days. The Joint Committee on Vaccination and Immunisation (JCVI) has reviewed evidence on the Pfizer/BioNTech COVID-19 vaccine and advised an interval of up to 12 weeks between doses. The considerations of the JCVI on extended intervals has been published, and is available here: <a href="https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement" target="_blank">https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement</a></p><p>Using data available from clinical trials, Public Health England estimated that vaccine efficacy from the first dose of the Pfizer/BioNTech vaccine is approximately 89%. This is the efficacy calculated 15 to 21 days after the first dose. The estimate for 15 to 28 days is 91% which includes seven days after the second dose, but is prior to the time protection that may be expected from the second dose. There is no estimate of efficacy for a single dose beyond 21 days, but the JCVI’s view is that protective immunity from the first dose likely lasts for a duration of 12 weeks.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 134547 134548 question first answered 18/01/2021 11:48:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73464 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4671 label Biography information for Afzal Khan

1274746

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the process is for arranging a covid-19 vaccination for carers employed directly by their client rather than by the NHS, a local authority or a private company.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	134439
answer	answer is ministerial correction date of answer 24/03/2021 answer text <p>All frontline health and social care workers are eligible regardless of who they are employed by as long as they are providing care and support to someone who is clinically vulnerable to Covid-19. This includes social care workers providing care in people’s own homes, day centres, care homes for working age adults or supported housing; whether they care for clinically vulnerable adults or children; or who they are employed by, whether private companies, charities, local authorities or the NHS.</p><p>If a carer is caring for multiple patients particularly vulnerable to COVID-19, the carer would be considered a frontline social care worker and therefore eligible for vaccination as a part of cohort 2.</p><p>Local authorities and employers will work together to identify frontline social care workers that are eligible to receive the vaccine, including directly employed personal assistants.</p><p>The Department advise self-employed social carer workers to contact the Adult Social Care lead for their Local Authority at the following link:</p><p><a href="https://www.gov.uk/government/publications/covid-19-vaccination-consent-form-and-letter-for-social-care-staff" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccination-consent-form-and-letter-for-social-care-staff</a>.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 24/03/2021 16:53:51 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73536 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4267 label Biography information for Sarah Champion

1274747

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what role community pharmacies will have in the delivery of the covid-19 vaccine.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	134411
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>Community pharmacies will play a major role in the COVID-19 vaccination programme. Since 11 January 2021, some community pharmacies have started to offer the COVID-19 vaccination service, with more pharmacies joining the service over the coming weeks.</p><p>Some pharmacists and members of their team have been working with general practitioners to deliver the vaccine in many areas of the country as part of the Primary Care Network service.</p><p>The Department, NHS England and NHS Improvement, and the community pharmacy representative bodies will be working together to establish how community pharmacies’ role could be expanded further in the vaccination programme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/01/2021 12:14:16 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73483 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380
tabling member	3973 label Biography information for Grahame Morris

1274784

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Leicestershire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to support community pharmacies in Leicestershire with the roll-out of covid-19 vaccinations.
tabling member constituency	Bosworth
tabling member printed	Dr Luke Evans
uin	134604
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>Community pharmacies providing the COVID-19 vaccination, regardless of their location in England, will be eligible for support in the form of training, funding for the service including fee per vaccination, additional venue hire costs and pre-agreed one off set up costs and non-monetary support - for example, access to vaccines, consumables, personal protective equipment and other equipment to operate the site.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/01/2021 09:18:21 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4781 label Biography information for Dr Luke Evans

1274814

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients in (a) Derbyshire and (b) Amber Valley constituency are in phase 1 priority groups for covid-19 vaccination.
tabling member constituency	Amber Valley
tabling member printed	Nigel Mills
uin	134428
answer	answer is ministerial correction date of answer 30/03/2021 answer text <p>The information requested at county level is not currently available. In addition, constituency level vaccination and eligibility data is not available in the format requested as of 7 January 2021.</p><p>Data on the number of vaccinations delivered is available at the following link:</p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 134429 134430 question first answered 30/03/2021 11:41:54 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73533 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4136 label Biography information for Nigel Mills

1274816

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Derbyshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients in (a) Derbyshire and (b) Amber Valley constituency are in the top four priority groups for covid-19 vaccination.
tabling member constituency	Amber Valley
tabling member printed	Nigel Mills
uin	134429
answer	answer is ministerial correction date of answer 30/03/2021 answer text <p>The information requested at county level is not currently available. In addition, constituency level vaccination and eligibility data is not available in the format requested as of 7 January 2021.</p><p>Data on the number of vaccinations delivered is available at the following link:</p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 134428 134430 question first answered 30/03/2021 11:41:54 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73534 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4136 label Biography information for Nigel Mills